Reckitt Benckiser emerged as a surprise suitor for perennial bid candidate Mead Johnson Nutrition, starting talks on a $16.7 billion purchase of the baby-food maker to build its faster growing consumer-health business and its presence in Asia.
The maker of Lysol cleaners said late Wednesday it’s in advanced negotiations to acquire the US company for $90 a share in cash in what would be the second-biggest acquisition by a British company since the Brexit vote.
Speculation of a bid for Mead Johnson has been rife since the maker of Enfamil went public in 2009, though Nestlé and French yogurt maker Danone have been considered the most likely buyers. Reckitt Benckiser Chief Executive Officer Rakesh Kapoor is striking as Danone is busy trying to complete its $10 billion acquisition of organic food maker WhiteWave Foods. Nestlé, whose new CEO just started last month, would face too many antitrust obstacles in such a transaction, analysts at RBC Europe have said.
“Reckitt Benckiser had never even been considered as a potential acquirer,” Andrew Wood, an analyst at Sanford C. Bernstein, said in a note. “Infant formula was considered too far away from its core business. Hence the news was very surprising to us.”
Full Content: Independent
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI